Qualigen Therapeutics to Present at the H.C. Wainwright BioConnect 2021 Conference

Rhea-AI Summary

Qualigen Therapeutics (Nasdaq: QLGN) will be presenting at the H.C. Wainwright BioConnect 2021 Virtual Conference from January 11-14, 2021. The presentation will be delivered by Michael Poirier, the Chairman and CEO of the company. Investors can access the presentation via webcast on-demand, starting January 11, 2021, on the Qualigen Therapeutics website, specifically in the Investors section.

CARLSBAD, Calif., Jan. 5, 2021 /PRNewswire/ -- Qualigen Therapeutics, Inc. (Nasdaq: QLGN), a biotechnology company focused on developing novel therapeutics for the treatment of cancer and infectious diseases, today announced that Michael Poirier, Chairman, Chief Executive Officer and President, will present at the H.C. Wainwright BioConnect 2021 Virtual Conference to be held January 11-14, 2021.

A webcast of the presentation will be accessible on demand beginning Monday, January 11, 2021 on the Qualigen Therapeutics website, https://www.qualigeninc.com/, in the Investors section.   

 

View original content:http://www.prnewswire.com/news-releases/qualigen-therapeutics-to-present-at-the-hc-wainwright-bioconnect-2021-conference-301200916.html

SOURCE Qualigen, Inc.

FAQ

When is Qualigen presenting at the H.C. Wainwright BioConnect 2021 Virtual Conference?

Qualigen Therapeutics will present at the conference from January 11-14, 2021.

Who will present on behalf of Qualigen at the conference?

Michael Poirier, the Chairman and CEO of Qualigen, will present at the conference.

How can I access the Qualigen presentation?

The presentation can be accessed via a webcast on-demand starting January 11, 2021, on the Qualigen Therapeutics website.

What is the stock symbol for Qualigen Therapeutics?

The stock symbol for Qualigen Therapeutics is QLGN.

Where can I find more information about Qualigen Therapeutics?

For more information, you can visit the Qualigen Therapeutics website.